William Blair Upgrades Korro Bio to Outperform From Market Perform
AI Sentiment
Positive
7/10
as of 02-17-2026 3:46pm EST
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
| Founded: | 2014 | Country: | N/A |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 101.1M | IPO Year: | N/A |
| Target Price: | $54.60 | AVG Volume (30 days): | 294.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $5.20 - $55.89 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 145.97% | Revenue Growth (next year): | -67.79% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
KRRO Breaking Stock News: Dive into KRRO Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
4/10
See how KRRO stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "KRRO Korro Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.